Therefore, although inactivation of p16 or p53 both can lead to accelerated PDAC development, it is possible that p53 inactivation can drive the development of an advanced type of tumor within a shorter time and cannot be completely rescued by NF-κB inhibition. Here, NFKB1 is linked to neoplasm.